M. K. Proteins
M. K. Proteins Limited engages in the manufacturing and trading of vegetable refined oil and by-products. The last earnings update was 25 days ago. More info.
Add to Portfolio Compare Print
MKPL Share Price and Events
7 Day Returns
1 Year Returns
MKPL Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| M. K. Proteins (MKPL) | -5% | -4% | -7.8% | -16.2% | - | - |
| IN Food | -1.7% | 1.2% | 0.2% | -2.5% | 58.8% | 130.3% |
| IN Market | -1.1% | -1.5% | 0.7% | -1.6% | 32.6% | 39.1% |
1 Year Return vs Industry and Market
- MKPL underperformed the Food industry which returned -2.5% over the past year.
- MKPL underperformed the Market in India which returned -1.6% over the past year.
Value
Is M. K. Proteins undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
- It is not possible to calculate the future cash flow value for M. K. Proteins. This is due to cash flow or dividend data being unavailable. The share price is ₹70.45.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for M. K. Proteins's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
M. K. Proteins's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2019-03-31) in INR | ₹3.94 |
| NSEI:MKPL Share Price ** | NSEI (2019-06-20) in INR | ₹70.45 |
| India Food Industry PE Ratio | Median Figure of 162 Publicly-Listed Food Companies | 17x |
| India Market PE Ratio | Median Figure of 2,825 Publicly-Listed Companies | 15.44x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of M. K. Proteins.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NSEI:MKPL Share Price ÷ EPS (both in INR) = 70.45 ÷ 3.94 |
17.88x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- M. K. Proteins is overvalued based on earnings compared to the IN Food industry average.
- M. K. Proteins is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does
M. K. Proteins's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 17.88x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts |
3.9%per year |
| India Food Industry PEG Ratio | Median Figure of 18 Publicly-Listed Food Companies | 1.62x |
| India Market PEG Ratio | Median Figure of 523 Publicly-Listed Companies | 1.32x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for M. K. Proteins, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
M. K. Proteins's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2019-03-31) in INR | ₹41.10 |
| NSEI:MKPL Share Price * | NSEI (2019-06-20) in INR | ₹70.45 |
| India Food Industry PB Ratio | Median Figure of 206 Publicly-Listed Food Companies | 0.93x |
| India Market PB Ratio | Median Figure of 3,653 Publicly-Listed Companies | 0.97x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NSEI:MKPL Share Price ÷ Book Value per Share (both in INR) = 70.45 ÷ 41.10 |
1.71x |
* Primary Listing of M. K. Proteins.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- M. K. Proteins is overvalued based on assets compared to the IN Food industry average.
Value checks
We assess M. K. Proteins's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Food industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Food industry average (and greater than 0)? (1 check) M. K. Proteins has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
- No analysts cover M. K. Proteins, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- M. K. Proteins's earnings growth is positive but not above the low risk savings rate of 7.6%.
Growth vs Market Checks
- M. K. Proteins's earnings growth is positive but not above the India market average.
- Unable to compare M. K. Proteins's revenue growth to the India market average as no estimate data is available.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NSEI:MKPL Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts | 3.9% |
| India Food Industry Earnings Growth Rate | Market Cap Weighted Average | 15.6% |
| India Food Industry Revenue Growth Rate | Market Cap Weighted Average | 13.6% |
| India Market Earnings Growth Rate | Market Cap Weighted Average | 16.7% |
| India Market Revenue Growth Rate | Market Cap Weighted Average | 9.9% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (2 months ago) | See Below |
| Future Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
| Date (Data in INR Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2019-03-31 | 1,568 | 16 | |
| 2018-03-31 | 1,717 | -120 | 14 |
| 2017-03-31 | 1,645 | -36 | 10 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (2 months ago) | See Below |
| Future Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
All data from M. K. Proteins Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in INR Millions) | EPS * |
|---|---|
| 2019-03-31 | 3.94 |
| 2018-03-31 | 3.42 |
| 2017-03-31 | 3.64 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Unable to establish if M. K. Proteins will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
Future performance checks
We assess M. K. Proteins's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
M. K. Proteins has a total score of 0/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has M. K. Proteins performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- M. K. Proteins has delivered over 20% year on year earnings growth in the past 5 years.
- M. K. Proteins's 1-year earnings growth is less than its 5-year average (15.2% vs 21.8%)
- M. K. Proteins's earnings growth has not exceeded the IN Food industry average in the past year (15.2% vs 15.3%).
Earnings and Revenue History
All data from M. K. Proteins Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in INR Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2019-03-31 | 1,568.46 | 16.43 | 17.01 | |
| 2018-03-31 | 1,716.76 | 14.27 | 17.71 | |
| 2017-03-31 | 1,645.35 | 9.86 | 18.64 | |
| 2016-03-31 | 1,447.53 | 7.22 | 13.90 | |
| 2015-03-31 | 1,232.33 | 8.37 | 11.36 | |
| 2014-03-31 | 1,217.33 | 4.94 | 7.78 | |
| 2013-03-31 | 854.01 | 5.32 | 4.49 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- M. K. Proteins has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- M. K. Proteins used its assets more efficiently than the IN Food industry average last year based on Return on Assets.
- M. K. Proteins's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess M. K. Proteins's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Food industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
M. K. Proteins has a total score of 2/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is M. K. Proteins's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up M. K. Proteins's finances.
The net worth of a company is the difference between its assets and liabilities.
- M. K. Proteins is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- M. K. Proteins's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 1.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from M. K. Proteins Company Filings, last reported 2 months ago.
| Date (Data in INR Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2019-03-31 | 171.42 | 259.23 | 0.04 |
| 2018-03-31 | 154.99 | 329.82 | 2.03 |
| 2017-03-31 | 42.56 | 307.68 | 0.35 |
| 2016-03-31 | 32.70 | 261.91 | 3.99 |
| 2015-03-31 | 25.40 | 197.05 | 0.23 |
| 2014-03-31 | 17.03 | 279.26 | 0.80 |
| 2013-03-31 | 12.09 | 181.55 | 3.79 |
- M. K. Proteins's level of debt (151.2%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has been reduced over the past 5 years (1636% vs 151.2% today).
- Operating cash flow is negative therefore debt is not well covered.
- Interest payments on debt are not well covered by earnings (EBIT is 2.5x annual interest expense, ideally 3x coverage).
Financial health checks
We assess M. K. Proteins's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) M. K. Proteins has a total score of 3/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is M. K. Proteins's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
₹2,000 of
M. K. Proteins
shares you are expected to receive
₹0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate M. K. Proteins's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate M. K. Proteins's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
| India Food Industry Average Dividend Yield | Market Cap Weighted Average of 72 Stocks | 0.9% |
| India Market Average Dividend Yield | Market Cap Weighted Average of 1449 Stocks | 1.4% |
| India Minimum Threshold Dividend Yield | 10th Percentile | 0.3% |
| India Bottom 25% Dividend Yield | 25th Percentile | 0.5% |
| India Top 25% Dividend Yield | 75th Percentile | 2.1% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as M. K. Proteins has not reported any payouts.
- Unable to verify if M. K. Proteins's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess M. K. Proteins's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can M. K. Proteins afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) M. K. Proteins has a total score of 0/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
| COMPENSATION | ₹0 |
| AGE | 55 |
| TENURE AS CEO | 2.4 years |
CEO Bio
Mr. Vinod Kumar has been Managing Director of M K Proteins Limited since January 02, 2017 and has been its Executive Director since December 10, 2016. He serves as the Chief Executive Officer of M. K. Proteins Ltd. Mr. Kumar is a businessman having rich experience of more than 30 years in the Edible Oil Industry. He was handling the complete refining process in Shib Charan Dass Industries Private Limited. He is involved in purchase of Edible and Non-Edible Oils. He is also responsible for quality control of the production/refining process of the oils. He holds graduation in BA from Kurukshetra University.
CEO Compensation
- Insufficient data for Vinod to compare compensation growth.
- Vinod's remuneration is lower than average for companies of similar size in India.
Management Team Tenure
Average tenure and age of the M. K. Proteins management team in years:
- The tenure for the M. K. Proteins management team is about average.
Management Team
Vinod Kumar
CEO, MD & Executive Director
55
2.4 yrs
Raj Kumar
Whole-Time Director
45
Nipun Garg
Chief Financial Officer
26
2.3 yrs
Sunila Garg
General Manager of Technical
Shipra Anand
Compliance Officer & Company Secretary
30
2.3 yrs
Kritika Garg
General Manager of Human Resource
Board of Directors Tenure
Average tenure and age of the M. K. Proteins board of directors in years:
- The average tenure for the M. K. Proteins board of directors is less than 3 years, this suggests a new board.
Board of Directors
Vinod Kumar
CEO, MD & Executive Director
55
2.5 yrs
Raj Kumar
Whole-Time Director
45
7 yrs
Chatter Singh
Non-Executive Independent Director
₹50K
76
2.3 yrs
Raman Kumar Sah
Non-Executive Independent Director
₹50K
32
2.3 yrs
Parvind Kumar
Non-Executive Director
₹1M
58
7 yrs
Parmod Kumar
Non-Executive Director
53
2.3 yrs
Abhay Kumar
Non-Executive Independent Director
₹50K
66
2.3 yrs
Dinesh Malik
Non-Executive Independent Director
₹50K
42
2.3 yrs
Laxmi Mandal
Non-Executive Independent Director
₹50K
34
2.3 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (₹) | Value (₹) | |
|---|---|---|---|---|---|---|---|---|---|---|
Management checks
We assess M. K. Proteins's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) M. K. Proteins has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
M. K. Proteins Limited (NSE:MKPL) Has A ROE Of 9.6%
The formula for ROE is: Return on Equity = Net Profit ÷ Shareholders' Equity Or for M. … In the latter case, the debt required for growth will boost returns, but will not impact the shareholders' equity. … In my book the highest quality companies have high return on equity, despite low debt?
Simply Wall St - – Full articleIs M. K. Proteins Limited’s (NSE:MKPL) 16% ROCE Any Good?
Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … Understanding Return On Capital Employed (ROCE). … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.
Simply Wall St - – Full articleM. K. Proteins (NSE:MKPL) Shareholders Booked A 29% Gain In The Last Year
Proteins Limited (NSE:MKPL) share price is 29% higher than it was a year ago, much better than the market return of around 2.7% (not including dividends) in the same periodK … Proteins for a while to get a better sense of its share price trend, since it hasn't been listed for particularly long! … By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
Simply Wall St - – Full articleWhat Kind Of Shareholders Own M. K. Proteins Limited (NSE:MKPL)?
Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. … I generally like to see some degree of insider ownership, even if only a little. … institutions are noticeable on the share registry.
Simply Wall St - – Full articleM. K. Proteins Limited (NSE:MKPL) Earns A Nice Return On Capital Employed
Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … What is Return On Capital Employed (ROCE). … ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business.
Simply Wall St - – Full articleHow Did M. K. Proteins Limited's (NSE:MKPL) 9.2% ROE Fare Against The Industry?
With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. … Proteins has a return on equity of 9.2% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity.
Simply Wall St - – Full articleDespite Its High P/E Ratio, Is M K Proteins Limited (NSE:MKPL) Still Undervalued?
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). … Proteins has a price to earnings ratio of 22.01, based on the last twelve monthsM … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS).
Simply Wall St - – Full articleWhat Kind Of Shareholder Owns Most M K Proteins Limited (NSE:MKPL) Stock?
Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. … Proteins is a smaller company with a market capitalization of ₹300m, so it may still be flying under the radar of many institutional investors. … institutions don't own shares in the company.
Simply Wall St - – Full articleIs M K Proteins Limited's (NSE:MKPL) PE Ratio A Signal To Sell For Investors?
The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market. … and want to begin learning the link between M K Proteins Limited (NSE:MKPL)’s fundamentals and stock market performance. … While MKPL might seem like a stock to avoid or sell if you own it, it is important to understand the assumptions behind the P/E ratio before you make any investment decisions
Simply Wall St - – Full articleShould You Be Tempted To Sell M K. Proteins Limited (NSE:MKPL) At Its Current PE Ratio?
It compares a stock’s price per share to the stock’s earnings per share. … Formula Price-Earnings Ratio = Price per share ÷ Earnings per share P/E Calculation for MKPL Price per share = ₹76.5 Earnings per share = ₹3.64 ∴ Price-Earnings Ratio = ₹76.5 ÷ ₹3.64 = 21x The P/E ratio isn’t a metric you view in isolation and only becomes useful when you compare it against other similar companies. … For example, if you are inadvertently comparing riskier firms with MKPL, then MKPL’s P/E would naturally be higher than its peers since investors would reward its lower risk with a higher price.
Simply Wall St - – Full articleCompany Info
Description
M. K. Proteins Limited engages in the manufacturing and trading of vegetable refined oil and by-products. The company offers refine rice bran, sunflower, cotton seed, soya bean, palm, canola, and rice bran bleached oils. It also provides by-products, such as rice bran fatty acid oils, rice bran waxes, gums, and spent earth; and imports and trades in edible and non-edible oils. M. K. Proteins Limited was founded in 2012 and is based in Ambala, India.
Details
| Name: | M. K. Proteins Limited |
| MKPL | |
| Exchange: | NSEI |
| Founded: | 2012 |
| ₹293,832,860 | |
| 4,170,800 | |
| Website: | http://www.mkproteins.in |
| Address: |
M. K. Proteins Limited Naraingarh Road, Village Garnala, Ambala, Haryana, 134003, India |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NSEI | MKPL | Equity Shares | National Stock Exchange of India | IN | INR | 11. Oct 2017 |
Number of employees
Current staff
Industry
| Packaged Foods and Meats | |
| Food, Beverage & Tobacco |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/06/24 13:09 |
| End of day share price update: | 2019/06/20 00:00 |
| Last earnings filing: | 2019/05/30 |
| Last earnings reported: | 2019/03/31 |
| Last annual earnings reported: | 2019/03/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
